Ayala Pharmaceuticals RPE

Mi az Ayala Pharmaceuticals RPE?

A RPE az Ayala Pharmaceuticals Inc. - $11.111k

Mi a RPE meghatározása?

Egy alkalmazottra jutó bevétel (RPE) a bevétel osztva a szervezet alkalmazottai számával.

RPE a Health Care szektor a NASDAQ-on cégekben a Ayala Pharmaceuticals -hoz képest

Mit csinál Ayala Pharmaceuticals?

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

rpe -hoz hasonló cégek Ayala Pharmaceuticals

International General Insurance Ltd nak RPE $10.651k van
Casino, Guichard-Perrachon SA nak RPE €10.771k van
RE/MAX Inc nak RPE $10.785k van
Oncocyte nak RPE $10.883k van
Watchstone Plc nak RPE £10.958k van
4Dx nak RPE AUD$11.098k van
Ayala Pharmaceuticals nak RPE $11.111k van
ANGLE Plc nak RPE £11.137k van
DynaCERT nak RPE CAD$11.150k van
Aguia Resources nak RPE AUD$11.200k van
ASA International PLC nak RPE $11.320k van
Verona Pharma Plc nak RPE $11.450k van
GOME Retail nak RPE ¥11.455k van